The role of IL-15 in the stimulation of CD8+ cytotoxic T and natural killer (NK) cell populations is well-characterized and has provided strong pre-clinical support for its use in cancer and vaccine immunotherapeutic approaches24, 27, 32, 33. Here, CD8A is linked to cancer.